Michael Makris on Non-Malignant Haematology
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared on LinkedIn:
”What do you call the specialty of “non-malignant haematology”?
Everybody agrees that non-malignant haematology is not a good term.
Our US colleagues, backed by ASH, have chosen to go with “Classical Hematology”.
I have discussed this with colleagues in the UK and Europe, and have not met a single haematologist who likes the term Classical Haematology.
We now have a new name proposed: Medical Haematology.
A paper in the British Journal of Haematology discusses this in detail, including why this term is preferred to Classical Haematology, and also how this is integrated with hospital medicine and the future of the specialty.
My personal view is that our specialty should be called Medical not Classical Haematology.”
Read the full article here.
Article: Medical haematology: Repositioning haematology at the centre of medicine
Authors: Cheng Hock Toh, Imelda Bates, Sue Pavord
Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers